Headlands Technologies’s Editas Medicine EDIT Stock Holding History

Headlands Technologies’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.3K	Buy	+11,853	New	+$25.1K	﹤0.01%	708
2025 Q4	–	Sell	-76,575	Closed	-$266K	–	712
2025 Q3	$266K	Buy	76,575 +69,391	+966%	+$194K	0.02%	491
2025 Q2	$15.8K	Buy	+7,184	New	+$11.8K	﹤0.01%	963
2024 Q2	–	Sell	-9,493	Closed	-$70.4K	–	1251
2024 Q1	$70.4K	Buy	9,493 +7,861	+482%	+$65.3K	0.02%	621
2023 Q4	$16.5K	Buy	+1,632	New	+$14.3K	﹤0.01%	693
2023 Q3	–	Sell	-5,758	Closed	-$47.4K	–	995
2023 Q2	$47.4K	Buy	+5,758	New	+$50.2K	0.02%	479

Other funds holding EDIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Headlands Technologies's EDIT Position: Q1 2026 in Review

Headlands Technologies opened a new position in Editas Medicine (EDIT) in Q1 2026: 11,853 shares worth $29.3K. The stake represents ﹤0.01% of the portfolio and ranks #708 among its holdings. This is a return to the name: Headlands Technologies previously reported a position in EDIT as recently as Q3 2025.

Headlands Technologies first reported a position in EDIT in Q2 2023 and has held it in 6 quarters since. The position peaked at $266K in Q3 2025. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

Headlands Technologies held 11,853 shares of Editas Medicine worth $29.3K as of Q1 2026.
Editas Medicine was a new Headlands Technologies position in Q1 2026.
Editas Medicine made up ﹤0.01% of Headlands Technologies's portfolio in Q1 2026, its #708 holding.
Headlands Technologies first reported a position in Editas Medicine in Q2 2023 and has held it in 6 quarters since.
Headlands Technologies's Editas Medicine position peaked at $266K in Q3 2025.
208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.